If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Elsevier

Related content
Volume 71, Number 6, December 1996

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Quality assurance after process changes of the production of a therapeutic antibody
pp. 395-403(9)
Authors: Brass, J.M.; Krummen, K.; Moll-Kaufmann, C.

Favourites:Add to Favourites

Quality assurance for biopharmaceuticals: An overview of regulations, methods and problems
pp. 421-438(18)
Authors: Muller, K.M.; Gempeler, M.R.; Scheiwe, M.; Zeugin, B.T.

Favourites:Add to Favourites

Requirements for the quality control of chemically synthesized peptides and biotechnologically produced proteins
pp. 439-446(8)
Authors: Bichsel, V.E.; Curcio, V.; Gassmann, R.; Otto, H.

Favourites:Add to Favourites

Special considerations concerning regulatory requirements and drug development for peptides and biotech products in the EU
pp. 447-458(12)
Authors: Braun, A.; Gassmann, R.; Kraus, K.; Lorenzi, G.; Weigel, U.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more